Literature DB >> 7690965

Characterization of distinct functional domains of transforming growth factor beta.

J K Burmester1, S W Qian, A B Roberts, A Huang, S Amatayakul-Chantler, L Suardet, N Odartchenko, J A Madri, M B Sporn.   

Abstract

Three distinct isoforms of transforming growth factor beta (TGF-beta) are expressed in mammalian cells. Although many cells respond equivalently to all three isoforms, certain cells respond selectively. Using chimeric proteins in which selected regions of the different isoforms were interchanged, we have identified two distinct functional domains of TGF-beta involved in determining the biological potencies and functions of the molecule. The first domain is important for determining whether TGF-beta can be sequestered by alpha 2-macroglobulin. By replacing aa 45 and 47 of TGF-beta 2 with the corresponding amino acids of TGF-beta 1, sequestration of the TGF-beta molecule by alpha 2-macroglobulin was markedly reduced. The second domain is functionally different from the alpha 2-macroglobulin sequestration site and is important for determining the potency of TGF-beta to inhibit growth of the LS513 human colorectal cancer cell line. Neither the TGF-beta 2/beta 1-(40-47) replacement construct nor a chimera containing aa 1-39 of TGF-beta 2, aa 40-82 of TGF-beta 1, and aa 83-112 of TGF-beta 2 was equivalent to TGF-beta 1 in inhibiting growth of LS513 cells. This fact suggests that additional amino acids outside of the aa 40-82 region are required to specify TGF-beta 1 activity with these cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7690965      PMCID: PMC47411          DOI: 10.1073/pnas.90.18.8628

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Differential inhibition of transforming growth factor beta 1 and beta 2 activity by alpha 2-macroglobulin.

Authors:  D Danielpour; M B Sporn
Journal:  J Biol Chem       Date:  1990-04-25       Impact factor: 5.157

2.  A general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions.

Authors:  R Higuchi; B Krummel; R K Saiki
Journal:  Nucleic Acids Res       Date:  1988-08-11       Impact factor: 16.971

3.  Cellular receptors for type beta transforming growth factor. Ligand binding and affinity labeling in human and rodent cell lines.

Authors:  J Massagué; B Like
Journal:  J Biol Chem       Date:  1985-03-10       Impact factor: 5.157

4.  Proliferin secreted by cultured cells binds to mannose 6-phosphate receptors.

Authors:  S J Lee; D Nathans
Journal:  J Biol Chem       Date:  1988-03-05       Impact factor: 5.157

5.  Membrane binding characteristics of two forms of transforming growth factor-beta.

Authors:  P R Segarini; A B Roberts; D M Rosen; S M Seyedin
Journal:  J Biol Chem       Date:  1987-10-25       Impact factor: 5.157

6.  Distinct transforming growth factor-beta (TGF-beta) receptor subsets as determinants of cellular responsiveness to three TGF-beta isoforms.

Authors:  S Cheifetz; H Hernandez; M Laiho; P ten Dijke; K K Iwata; J Massagué
Journal:  J Biol Chem       Date:  1990-11-25       Impact factor: 5.157

7.  Comparison of the biological actions of TGF beta-1 and TGF beta-2: differential activity in endothelial cells.

Authors:  J C Jennings; S Mohan; T A Linkhart; R Widstrom; D J Baylink
Journal:  J Cell Physiol       Date:  1988-10       Impact factor: 6.384

8.  Two forms of transforming growth factor-beta distinguished by multipotential haematopoietic progenitor cells.

Authors:  M Ohta; J S Greenberger; P Anklesaria; A Bassols; J Massagué
Journal:  Nature       Date:  1987 Oct 8-14       Impact factor: 49.962

9.  Inactivation of the type II receptor reveals two receptor pathways for the diverse TGF-beta activities.

Authors:  R H Chen; R Ebner; R Derynck
Journal:  Science       Date:  1993-05-28       Impact factor: 47.728

10.  Differential proliferative effects of transforming growth factor-beta on human hematopoietic progenitor cells.

Authors:  O G Ottmann; L M Pelus
Journal:  J Immunol       Date:  1988-04-15       Impact factor: 5.422

View more
  6 in total

1.  alpha2-macroglobulin modulates the immunoregulatory function of the lipocalin placental protein 14.

Authors:  G J Riely; J Rachmilewitz; P H Koo; M L Tykocinski
Journal:  Biochem J       Date:  2000-10-15       Impact factor: 3.857

2.  Complex flexibility of the transforming growth factor beta superfamily.

Authors:  G Venkataraman; V Sasisekharan; C L Cooney; R Langer; R Sasisekharan
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-06       Impact factor: 11.205

Review 3.  Medical applications of transforming growth factor-beta.

Authors:  Kathleen C Flanders; James K Burmester
Journal:  Clin Med Res       Date:  2003-01

4.  Molecular lesions associated with alleles of decapentaplegic identify residues necessary for TGF-beta/BMP cell signaling in Drosophila melanogaster.

Authors:  K Wharton; R P Ray; S D Findley; H E Duncan; W M Gelbart
Journal:  Genetics       Date:  1996-02       Impact factor: 4.562

5.  Differences in the binding of transforming growth factor beta 1 to the acute-phase reactant and constitutively synthesized alpha-macroglobulins of rat.

Authors:  D J Webb; K P Crookston; N L Figler; J Lamarre; S L Gonias
Journal:  Biochem J       Date:  1995-12-01       Impact factor: 3.857

6.  Differential modulation of transforming growth factor-betas and cyclooxygenases in the platelet lysates of male F344 rats by dietary lipids and piroxicam.

Authors:  Jayadev Raju; Ranjana P Bird
Journal:  Mol Cell Biochem       Date:  2002-02       Impact factor: 3.396

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.